期刊文献+

心力衰竭患者血清可溶性ST2受体的变化及意义 被引量:4

The changes and significance of soluble ST2 receptor in heart failure patients
下载PDF
导出
摘要 目的测定心力衰竭患者不同时间点的血清可溶性ST2受体浓度,分析其在心力衰竭早期诊断及病情评估方面的意义。方法选择心力衰竭患者60例作为实验组,对照组60例。评价其心功能情况及临床变化。ELISA法测定患者入院时、第3天血清可溶性ST2受体水平、N-末端脑利钠肽前体及测定入院时的左室射血分数。结果实验组血清可溶性ST2受体(s ST2)水平显著高于对照组,左心室射血分数显著低于对照组,差异均有统计学意义(P<0.05)。血清可溶性ST2受体(s ST2)水平与N-末端脑利钠肽前体呈正相关(P<0.01),与左心室射血分数(LVEF)呈负相关(P<0.01)。结论血清可溶性ST2受体(s ST2)浓度可以作为判断患者有无心力衰竭的实用指标,并且对于心力衰竭严重程度的判断有重要的指导意义,指导临床诊断及治疗。由于s ST2浓度与LVEF值呈负相关,有望通过s ST2浓度来预测患者的LVEF值。 Objective To determine concentrations of serum soluble ST2 receptors(sST2) of patients with heart failure at different time points and analyze its significance in early diagnosis and Condition assessment of heart failure. Methods Sixty patients with heart failure were taken as the experiment group and 60 people without heart failure were taken as the control group. Their cardiac function and clinical changes were evaluated. The ELISA method was used to measure the serum soluble ST2 receptors concentration on admission and on the 3th day and measure left ventricular ejection fraction(LVEF)and N-terminal pro-brain natriuretic peptide precursors(NT-proBNP). Results The experment group was significantly higher than the control group in the serum sST2 level and was significantly lower in theLVEF, with statistically significant difference (P〈0.05). The sST2 concentration and NT-proBNP value was positively correlated (P〈 0.01 ),and was negative correlation with the left ventricular ejection fraction(P〈0.01 ). Conclusion Serum sST2 concentration can be used as a judge whether there arc heart failure patients with sensitive index, and can be used to judge the severity of heart failure, because the sST2 concentration and LVEF value is negatively correlated, is expected to through the sST2 concentration to predict the patients LVEF value.
出处 《中国现代医生》 2014年第32期16-18,共3页 China Modern Doctor
基金 广东省清远市第一批科技计划项目(2011B011112011)
关键词 心力衰竭 血清可溶性ST2受体 诊断 Heart failure Serum soluble ST2 receptor(sST2) Diagnosis
  • 相关文献

参考文献11

  • 1Sanada S,Hakuno D,Higgins LJ,et al. IL-33 and ST2 comprise a critical biomechanically induced and cardio- protective signaling system[J]. Clin Invest, 2007,117 (6) : 1538-1549.
  • 2McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure:The framingham study[J]. N Engl J Med, 1971,285 (26) : 1441-1446.
  • 3李红霞,陈建华.血浆脑钠肽对心力衰竭诊断及预后判断的临床分析[J].中华全科医学,2011,9(8):1209-1210. 被引量:57
  • 4Tschope C, Kasner M, Westermannd D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dys- function :Correlation with echocardiographic and invasive measurements[J]. Eur Heart J, 2005,26 (21 ) : 2277 -2284.
  • 5陈纯波,孙诚,吴粤.充血性心力衰竭患者血浆N-端脑利钠肽前体水平的变化[J].实用医学杂志,2005,21(11):1164-1165. 被引量:20
  • 6Mottram PM, Marwick TH. Assessment of diastolic func- tion:what the general cardiologist needs to know[J]. Heart, 2005,91 (5) : 681-695.
  • 7Grewal J ,Mckelvie R,Lonne, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction[J]. Eur J Heart Fail, 2008,10 (3) : 252-259.
  • 8Lee JH,Wang LC,Yu HH,et al. Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma[J]. Mediators Inflamm, 2010,20 ( 13 ) : 567-573.
  • 9Ali S,Huber M,Kollewe C,et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells[J]. Proc Natl Acad Sci USA, 2007. 104(47) :18660-18665.
  • 10Sanada S,Hakuno D,Higgins LJ,et al. IL-33 and ST2 comprise a critical biomechanically induced and cardio protective signaling system[J]. J Clin Invest,2007,117 (6) : 1538-1549.

二级参考文献14

共引文献74

同被引文献48

  • 1Shah AS, Langrish JP, Nair H, et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet, 2013, 382: 1039-1048.
  • 2Felker GM, Fiuzat M, Shaw LK, et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail, 2012, 5: 72-78.
  • 3Laneellotti P, Dulgheru R, Magne J, et al. Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis. PLoS One, 2015, 10: e0138940.
  • 4Duan F, Qi Z, Liu S, et al. Effectiveness of bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: an echoeardiographie study of left ventricular remodeling. Med Uhrason, 2015 , 17: 160- 166.
  • 5Ahuja K, Crooke GA, Grossi EA, et al. Reversing left ventricular remodeling in chronic heart failure: surgical approaches. Cardiol Rev, 2007, 15: 184-190.
  • 6Sun RR, Lu L, Liu M, et al. Biomarkers and heart disease. Eur Rev Med Pharmacol Sci, 2014, 18: 2927-2935.
  • 7de Boer RA, van Veldhuisen D J, Gansevoort RT, et aL The fibrosis marker galectin-3 and outcome in the general population. J Intern Med, 2012, 272: 55-64.
  • 8van der Velde AR, Lexis CP, Meijers WC, et al. Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clin Chim Acta, 2016, 452: 50-57.
  • 9Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytcs and myocardial infarction. Circulation, 2002, 106: 2961-2966.
  • 10Figal DAP,Llanos JO,Tornel PL,袁志敏(摘译).可溶性ST2可预测收缩功能不全性心力衰竭者猝死风险[J].心血管病学进展,2010,31(6):925-925. 被引量:1

引证文献4

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部